Pharmaceuticals

Rheumatology Therapeutics Market Forecast Showing Industry Progress And Growth Trends

May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Rheumatology Therapeutics Market During 2026–2030?

The rheumatology therapeutics market size has seen consistent expansion in recent years. It is forecast to grow from $44.18 billion in 2025 to $46.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.5%. During the historical period, this growth was primarily driven by the increasing prevalence of rheumatoid arthritis and osteoarthritis, the wider availability of NSAIDs and corticosteroids, enhanced diagnosis of rheumatic diseases, rising healthcare access in developed markets, and the growing utilization of conventional synthetic DMARDs.

The rheumatology therapeutics market size is anticipated to demonstrate consistent growth over the coming years. It is predicted to expand to $54.16 billion by 2030, with a compound annual growth rate (CAGR) of 4.1%. This growth during the forecast period can be attributed to several factors, including an escalating demand for biologic DMARDs, an expanding aging demographic affected by chronic joint disorders, heightened awareness regarding early diagnosis and treatment, the proliferation of targeted synthetic DMARDs, and increased healthcare spending on chronic disease management. Noteworthy trends expected in this period encompass the rising adoption of biologic and targeted DMARDs, a strategic shift towards early and aggressive disease management, a greater utilization of combination therapies in rheumatic diseases, a reinforced emphasis on achieving long-term disease remission, and the broadening of personalized treatment approaches within rheumatology.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17246&type=smp

Which Major Drivers Are Influencing The Expansion Of The Rheumatology Therapeutics Market?

The expansion of the rheumatology therapeutics market is anticipated to be fueled by the increasing occurrence of autoimmune diseases. Such diseases involve the immune system erroneously targeting and harming the body’s own tissues. The rise in autoimmune disease prevalence can be attributed to a mix of genetic predispositions, environmental influences, and lifestyle choices, alongside better diagnostic tools and heightened public awareness. Rheumatology treatments are essential for managing inflammation, easing symptoms, and preventing harm to joints and tissues that results from the immune system’s attack on the body in these conditions. For example, data from June 2024, released by the Australian Institute of Health and Welfare, a government body in Australia, indicated that approximately 514,000 individuals in Australia, representing 2.0% of the population, were estimated to have rheumatoid arthritis in 2022. Rheumatoid arthritis constituted 2.0% of the overall disease burden and 16% of the burden specifically for all musculoskeletal conditions during 2023. Consequently, the increasing incidence of autoimmune diseases is propelling the expansion of the rheumatology therapeutics market.

How Is The Rheumatology Therapeutics Market Broken Down By Segment Categories?

The rheumatology therapeutics market covered in this report is segmented –

1) By Drug Class: Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Other Drugs Classes

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

3) By Disease Indication: Rheumatoid Arthritis, Osteoarthritis, Gout, Psoriatic Arthritis, Ankylosing Spondylitis, Other Disease Indications

Subsegments:

1) By Disease Modifying Anti-Rheumatic Drugs (DMARDs): Conventional Synthetic DMARDs, Biologic DMARDs, Targeted Synthetic DMARDs

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): COX-2 Inhibitors, Traditional NSAIDs

3) By Corticosteroids: Oral Corticosteroids, Injectable Corticosteroids, Topical Corticosteroids

4) By Uric Acid Drugs: Uric Acid Lowering Agents, Uricosuric Agents, Pegloticase

5) By Other Drug Classes: Immunosuppressants, Biologic Therapies, Analgesics

Which Trends Are Influencing Demand In The Rheumatology Therapeutics Market?

Key players in the rheumatology therapeutics market are pursuing inventive remedies, such as intravenous (IV) formulations, to bolster treatment effectiveness and patient ease. An intravenous (IV) formulation signifies a medicine or substance delivered directly into a vein using a needle or catheter. For example, in October 2023, Novartis AG, a Switzerland-based pharmaceutical company, announced the US Food and Drug Administration (FDA) had cleared Cosentyx, an intravenous (IV) formulation. This particular form of Cosentyx is uniquely sanctioned for treating adults diagnosed with psoriatic arthritis (PsA), ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA). Its mechanism involves specifically targeting and inhibiting interleukin-17A (IL-17A), positioning it as the singular non-tumor necrosis factor alpha (TNF-a) IV treatment available for these conditions.

Which Players Are Present In The Rheumatology Therapeutics Market Space?

Major companies operating in the rheumatology therapeutics market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Roche Holding AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company, Amgen Inc., UCB S.A., Sanofi SA, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Janssen Biotech, Genentech Inc., Galapagos NV

Get The Full Rheumatology Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report

Which Region Is The Largest In The Rheumatology Therapeutics Market?

North America was the largest region in the rheumatology therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rheumatology therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Rheumatology Therapeutics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report

Browse Through More Reports Similar to the Global Rheumatology Therapeutics Market 2026, By The Business Research Company

Rheumatology Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report

Rheumatoid Arthritis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report

Rheumatoid Arthritis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795